Consumer prices rose 2.9% in August from a year earlier, the Labor Department said Tuesday, the biggest increase since ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk, facing competition in the obesity drug market, has instructed employees to return to the office to enhance ...

Novo Nordisk has mandated a return to office work for all staff to speed up decision-making and improve market execution, ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

Stocks have been hitting records in large part because Wall Street is expecting the economy to pull off a delicate balancing ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

The Danish pharmaceutical company Novo Nordisk is cutting 9,000 jobs, 4,000 of which will be outside Denmark. The company, ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...